Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An electronic case manager for diabetes control

L F Meneghini1, A M Albisser, R B Goldberg

  • 1Diabetes Research Institute, Eleanor and Joseph Kosow Diagnostic and Treatment Center, University of Miami School of Medicine, FL 33101, USA. lmeneghi@mednet.med.miami.edu

Diabetes Care
|May 8, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program.

The Journal of clinical endocrinology and metabolism·2015
Same author

Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2015
Same author

The disappearing high density lipoprotein syndrome.

Journal of clinical lipidology·2015
Same author

Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance.

Diabetes, obesity & metabolism·2013
Same author

Incretin-based therapy in combination with basal insulin: a promising tactic for the treatment of type 2 diabetes.

Diabetes & metabolism·2012
Same author

The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries.

Diabetes, obesity & metabolism·2012
Same journal

A Secular Increase in the Incidence of Islet Autoimmunity Among Colorado Children With Moderate-Risk HLA Genotypes.

Diabetes care·2026
Same journal

Clinical and Biochemical Recovery From Immune Checkpoint Inhibitor-Induced Diabetes With Seroconversion of GAD Antibodies.

Diabetes care·2026
Same journal

State Insulin Out-of-Pocket Cap Policies and Estimated Eligible Populations in the United States, 2019-2026.

Diabetes care·2026
Same journal

Genetic Determinants of Macronutrient Intake Are Associated With Specific Food Intake in Youth: A Cohort Study Across Childhood and Adolescence.

Diabetes care·2026
Same journal

A Novel Electronic Medical Record Search Method to Identify Patients With Ketosis-Prone Diabetes: Implications for Discovery of Atypical Diabetes.

Diabetes care·2026
Same journal

Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.

Diabetes care·2026
See all related articles

An electronic case manager (ECM) system improved diabetes care by reducing crises and clinic visits. This technology offers patients timely, cost-effective intervention, enhancing overall diabetes management.

Area of Science:

  • Diabetes Management
  • Health Informatics
  • Telemedicine

Background:

  • Sustained glycemic control is crucial for preventing long-term diabetes complications.
  • Electronic Case Manager (ECM) systems offer a novel approach to facilitate diabetes care.

Purpose of the Study:

  • To evaluate the usage and safety of a voice-interactive ECM system.
  • To assess the impact of the ECM on glycemic control and patient outcomes.

Main Methods:

  • A customized microcomputer system served as the ECM, accessible via touch-tone telephone.
  • Beta-testing involved 184 patients in an academic diabetes center over 788 patient-months.
  • Patients reported glucose levels and symptoms; the system provided 24-h assistance and automated reporting.

Related Experiment Videos

Main Results:

  • 58% of patients actively used the ECM, with over 45,000 calls received in the first year.
  • Diabetes-related crises decreased threefold (P < 0.05).
  • HbA1c levels decreased by 0.8% at 6 months and 0.9% at 12 months (P < 0.05).
  • Clinic visits were reduced twofold (P < 0.0001).

Conclusions:

  • The ECM system provides timely, cost-effective, and reliable medical intervention for diabetes patients.
  • Utilizing the ECM reduces the incidence of diabetic crises and the need for frequent clinic visits.
  • The ECM empowers healthcare providers to deliver safer and superior diabetes care.